Brief: Vigil Neuroscience Inc Launches Alspaware To Provide Access To No-Cost Genetic Testing And Counseling For Adult-Onset Leukoencephalopathy With Alsp
08/05/2023 15:20
May 8 (Reuters) - Vigil Neuroscience Inc VIGL.O :
* VIGIL NEUROSCIENCE INC- LAUNCHES ALSPAWARE TO PROVIDE
ACCESS TO
NO-COST GENETIC TESTING AND COUNSELING FOR ADULT-ONSET
LEUKOENCEPHALOPATHY WITH ALSP
Source text for Eikon: ID:nGNX1kZTTF
Further company coverage: VIGL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vigil Neuroscience
See all newsVigil Neuroscience Inc reports results for the quarter ended June 30 - Earnings Summary
Vigil Neuroscience Inc expected to post a loss of 42 cents a share - Earnings Preview
Brief: Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
U.S. RESEARCH ROUNDUP-Ralph Lauren, Vigil Neuroscience, Workday
Deals of the day-Mergers and acquisitions